Suppr超能文献

脾脏边缘区淋巴瘤中全局 microRNA 表达失调及慢性丙型肝炎病毒感染的影响。

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.

机构信息

Department of Internal Medicine 1, J.W. Goethe-University Hospital, Frankfurt, Germany.

出版信息

Leukemia. 2012 Jul;26(7):1654-62. doi: 10.1038/leu.2012.29. Epub 2012 Feb 6.

Abstract

The precise molecular pathogenesis of splenic marginal zone lymphoma (SMZL) is still unknown. Clinical and epidemiological data suggest that chronic hepatitis C virus (HCV) infection may have an etiological role in a subset of cases.We performed a large-scale microRNA (miRNA) expression profiling analysis of 381 miRNAs by quantitative reverse transcription PCR (Q-RT-PCR) of 26 microdissected splenic tissue samples (7 HCV(+) SMZL; 8 HCV(-) SMZL and 11 non-neoplastic splenic controls). Single assay Q-RT-PCR and miRNA in situ hybridization (miRNA-ISH) were used to confirm the results in an independent cohort. Unsupervised hierarchical clustering of miRNA expression profiles demonstrated a distinct signature of SMZL compared with the normal splenic marginal zone. Supervised analysis revealed differentially expressed miRNAs, including miRNAs with previously recognized tumor suppressive or oncogenic potential. Five miRNAs were found significantly overexpressed in SMZL, including miR-21, miR-155 and miR-146a, whereas seven miRNAs showed significantly reduced expression, including miR-139, miR-345, miR-125a and miR-126. Furthermore, we identified miR-26b, a miRNA known to have tumor suppressive properties, as significantly downregulated in SMZL arising in HCV-positive patients (P=0.0016). In conclusion, there is a characteristic dysregulation of miRNA expression in SMZL with a possible implication in its molecular tumorigenesis.

摘要

脾边缘区淋巴瘤(SMZL)的确切分子发病机制尚不清楚。临床和流行病学数据表明,慢性丙型肝炎病毒(HCV)感染可能在部分病例中具有病因作用。我们通过对 26 个微切割脾组织样本(7 例 HCV(+) SMZL;8 例 HCV(-) SMZL 和 11 例非肿瘤性脾对照)进行定量逆转录 PCR(Q-RT-PCR),对 381 个 microRNA(miRNA)进行了大规模 miRNA 表达谱分析。单测定 Q-RT-PCR 和 miRNA 原位杂交(miRNA-ISH)用于在独立队列中确认结果。miRNA 表达谱的无监督层次聚类显示与正常脾边缘区相比,SMZL 具有明显的特征。有监督分析显示差异表达的 miRNA,包括具有先前公认的肿瘤抑制或致癌潜能的 miRNA。在 SMZL 中发现 5 个 miRNA 明显过表达,包括 miR-21、miR-155 和 miR-146a,而 7 个 miRNA 表达明显降低,包括 miR-139、miR-345、miR-125a 和 miR-126。此外,我们还发现了 miR-26b,一种已知具有肿瘤抑制特性的 miRNA,在 HCV 阳性患者中 SMZL 中显著下调(P=0.0016)。总之,SMZL 存在 miRNA 表达的特征性失调,可能与其分子发生有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验